Ca2+ release from host intracellular stores and related signal transduction during Campylobacter jejuni 81-176 internalization into human intestinal cells.
Campylobacter jejuni is the leading bacterial cause of human diarrhoeal disease in many parts of the world, including the USA. The ability of C. jejuni to invade the host intestinal epithelium is an important determinant of virulence. A common theme among pathogenic invasive micro-organisms is their ability to usurp the eukaryotic cell-signalling systems both to allow for invasion and to trigger disease pathogenesis. Ca(2+) is very important in a great variety of eukaryotic cell-signalling processes (e.g. calmodulin-activated enzymes, nuclear transcriptional upregulation, and cytoskeletal rearrangements). This study analyses the effects of Ca(2+) availability on invasion of human INT407 intestinal epithelial cells by C. jejuni strain 81-176. The ability of C. jejuni to invade INT407 cells was not blocked by chelation of any remaining extracellular Ca(2+) from host cells incubated in Ca(2+)-free, serum-free media. In contrast, C. jejuni invasion was markedly reduced either by chelating host intracellular Ca(2+) with 1,2-bis-(2-)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester (BAPTA, AM) or by blocking the release of Ca(2+) from intracellular stores with dantrolene or U73122. Moreover, Bay K8644, a plasma-membrane Ca(2+)-channel agonist, was observed to stimulate C. jejuni invasion, presumably by increasing host intracellular free Ca(2+) levels. Measurement of host-cell cytosolic Ca(2+) via spectrofluorimetry and fluorescence microscopy revealed an increase in Ca(2+) from 10 min post-infection. Monolayer pretreatment with either a calmodulin antagonist or a specific inhibitor of protein kinase C was found to cause a marked reduction in C. jejuni invasion, suggesting roles for these Ca(2+)-activated modulators in signal-transduction events involved in C. jejuni invasion. These results demonstrate that C. jejuni induces the mobilization of Ca(2+) from host intracellular stores, which is an essential step in the invasion of intestinal cells by this pathogen.
Hu
Lan
L
Laboratory of Enteric and Sexually Transmitted Diseases, FDA-Center for Biologics Evaluation and Research, 29 Lincoln Drive, Bldg 29/420 HFM440, Bethesda, MD 20892, USA.
Raybourne
Richard B
RB
Virulence Assessment, FDA-Center for Food Safety and Nutrition, Laurel, MD 20708, USA.
Kopecko
Dennis J
DJ
Laboratory of Enteric and Sexually Transmitted Diseases, FDA-Center for Biologics Evaluation and Research, 29 Lincoln Drive, Bldg 29/420 HFM440, Bethesda, MD 20892, USA.
D002118:Calcium / Q000378:metabolism* / Q000502:physiology; D002169:Campylobacter Infections / Q000378:metabolism* / Q000382:microbiology; D016123:Campylobacter jejuni / Q000378:metabolism / Q000472:pathogenicity / Q000502:physiology*; D002460:Cell Line; D015964:Gene Expression Regulation, Bacterial; D006801:Humans; D007422:Intestines / Q000382:microbiology*; D007425:Intracellular Membranes / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D014018:Tissue Distribution
D002118:Calcium